{"nct_id":"NCT06567743","title":"Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2024-09-16","start_date_type":"ACTUAL","primary_completion_date":"2027-03-31","primary_completion_date_type":"ESTIMATED","completion_date":"2027-12-30","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["CGON"]}